Qyuns Therapeutics Co (HKSE:02509) EPS (Basic): HK$1.56 (TTM As of Dec. 2025)


HKSE:02509 Qyuns Therapeutics Co Ltd HKSE:02509
9 GF Score
Price HK$13.62
! 6 Warning Signs
View Full Analysis

What is Qyuns Therapeutics Co EPS (Basic)?

Qyuns Therapeutics Co HKSE:02509 -2.16% 9 EPS (Basic) is HK$1.56 as of Dec. 2025. GuruFocus rates HKSE:02509 with a GF Score™ of 9/100. The stock has 6 warning signs investors should review.

Qyuns Therapeutics Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was HK$1.70. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1.56.

Qyuns Therapeutics Co's EPS (Diluted) for the six months ended in Dec. 2025 was HK$1.70. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1.56.

Qyuns Therapeutics Co's EPS without NRI for the six months ended in Dec. 2025 was HK$1.71. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 1.56.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Qyuns Therapeutics Co's highest 3-Year average EPS without NRI Growth Rate was -19.10% per year. The lowest was -19.10% per year. And the median was -19.10% per year.

Qyuns Therapeutics Co  (HKSE:02509) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Qyuns Therapeutics Co EPS (Basic) Related Terms

Qyuns Therapeutics Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Qyuns Therapeutics Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qyuns Therapeutics Co EPS (Basic) Chart

Qyuns Therapeutics Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
-2.27 -1.50 -2.50 -1.63 1.56

Qyuns Therapeutics Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial -1.23 -0.85 -0.79 -0.14 1.70
HKSE:02509
9GF Score
Qyuns Therapeutics Co Ltd HKSE:02509
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qyuns Therapeutics Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Qyuns Therapeutics Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(347.381-0)/223.695
=1.55

Qyuns Therapeutics Co's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(378.681-0)/225.318
=1.68

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of HK$1.56 mean?
Qyuns Therapeutics Co (HKSE:02509) has a EPS (Basic) of HK$1.56 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Qyuns Therapeutics Co and its competitors.
Is Qyuns Therapeutics Co's EPS (Basic) too high?
Qyuns Therapeutics Co's current EPS (Basic) is HK$1.56. Overall, Qyuns Therapeutics Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Qyuns Therapeutics Co's EPS (Basic) compare to VRTX and REGN?
Qyuns Therapeutics Co's EPS (Basic) of HK$1.56 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Qyuns Therapeutics Co and its competitors. Qyuns Therapeutics Co's current EPS (Basic) is HK$1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qyuns Therapeutics Co stock overvalued right now?
Qyuns Therapeutics Co (HKSE:02509) has a current EPS (Basic) of HK$1.56. The current EPS (Basic) is HK$1.56. Qyuns Therapeutics Co's overall GF Score™ is 9/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Qyuns Therapeutics Co (HKSE:02509), the current EPS (Basic) is HK$1.56 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Qyuns Therapeutics Co Business Description

Address No. 907 Yaocheng Avenue, Room 1310, Building 1, Taizhou, Jiangsu, CHN
Qyuns Therapeutics Co Ltd is a clinical-stage biotech company focused on biologic therapies for autoimmune and allergic diseases, with a self-developed drug pipeline. It has built a pipeline that covers the four disease areas in the field, including skin, rheumatic, respiratory, and digestive diseases. The group is principally engaged in the research and development, manufacturing, and commercialisation of biologic therapies for autoimmune and allergic diseases. Key revenue is generated from the PRC.
9GF Score

Get the complete analysis for HKSE:02509

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$13.62
Price